On 25.06.2015, a Memorandum of Understanding was signed between India and United States of America (USA) for cooperation, prevention, control and management in the field of Cancer Research and Environmental and Occupational Health. A Letter of Intent (LoI) on Antimicrobial Resistance Research was also signed between the two countries on the same day.
The objective of the MoU is to strengthen the promotion and development of cooperation in the fields of clinical cancer research and patient care delivery; Infrastructure development, training, and capacity building; collaboration in cancer research including basic, translational and survivorship research, epidemiology, prevention, diagnosis, screening, treatment and control; collaboration between Centers of Excellence and Institutions in both countries; and assessment and application of new and cost effective cancer diagnostic technologies for public health benefits, and the translation of technologies for global health.
The objective of the Letter of Intent (LoI) is to strengthen cooperation between the two countries in antimicrobial resistance research to include, mechanism of antimicrobial resistance, comparative testing and assisting the validation of new diagnostics, development of novel interventions, exploration of possible patterns of AMR in neonatal intensive care units as observed in India and the US, exploration of possible collaboration in clinical studies to determine new and combinations/uses of old drugs etc.